The present study was conducted to investigate the effects of repeated treatment with morphine on the drug's antinociceptive effects, intestinal absorption, and transepithelial transport. The antinociceptive effects of morphine in rats were markedly decreased after repeated oral administration of the drug for 5 d, indicating the development of tolerance. In the morphine-tolerant rats, intestinal absorption of morphine was determined using the in situ loop method. Absorption of morphine from the jejunum was significantly decreased after repeated administration. The permeability of human intestinal epithelial Caco-2 cells was increased in the efflux direction after repeated treatment. The repeated administration of morphine also reduced the cellular accumulation and efflux of P-glycoprotein substrates ([ 3 H]vincristine and rhodamine123) from Caco-2 cells, suggesting that it enhances P-glycoprotein-mediated efflux in Caco-2 cells. These results suggest that repeated use enhances the efflux of morphine in the epithelial cells of the small intestine, subsequently decreasing its intestinal absorption.
Chronic treatment with morphine is associated with the development of tolerance. The mechanism underlying this phenomenon has been investigated at the cellular and molecular level, but is poorly understood at the in vivo level. In vivo pharmacologic actions of drugs are generally dependent on both pharmacokinetic and pharmacodynamic factors. 3) Pharmacokinetic processes should be considered to elucidate the mechanism of morphine tolerance in vivo. In particular, P-glycoprotein (ABCB1, an MDR1 gene product), a drug resistance-related transporter, affects the intestinal absorption of morphine in humans and the distribution of morphine in the brain in mice and rats. [4] [5] [6] [7] [8] Aquilante et al. reported that repeated morphine administration caused a two-fold increase in the level of P-glycoprotein in the rat brain associated with a decrease in the antinociceptive effects. 9) King et al. also reported that an antisense-oligo against mdr1a suppressed the development of antinociceptive tolerance to intracerebroventricularly administered morphine. 10) Those results suggest that P-glycoprotein at the brain barrier is involved in the development of morphine tolerance. On the other hand, Yousif et al. reported that chronic morphine treatment did not alter P-glycoprotein activity in the blood-brain barrier in rats. 11) In patients treated with a sustained-release dosage form of morphine, P-glycoprotein in the intestine is more significantly affected than that at the blood-brain barrier, since the intestinal epithelium might be exposed to a relatively high concentration of morphine in a sustained manner. It was reported that intestinal Pglycoprotein affects morphine absorption in humans 4) and rats. 12, 13) The previous studies led to the assumption that repeated treatment with morphine causes an increase in intestinal P-glycoprotein-mediated transport, subsequently leading to a decrease in the oral bioavailability of this drug. Such a pharmacokinetic mechanism may be partly associated with the development of morphine tolerance.
The present study was undertaken to examine the effects of repeated treatment with morphine on its antinociception and on the intestinal absorption of this drug in rats. Further, we examined the effects of repeated treatment with morphine on transepithelial transport and on P-glycoprotein-mediated transport activity in Caco-2 cells, an in vitro model often used to evaluate intestinal drug permeability.
MATERIALS AND METHODS

Materials
Male Sprague-Dawley rats weighing about 250 g were housed 3 to 4 per cage with free access to food and water and maintained on a 12 h-light/dark cycle in a room with controlled temperature (24Ϯ1°C) and humidity (55Ϯ5%). Caco-2 cells were obtained from the American Type Culture Collection (Manassas, VA, U.S.A.), maintained at subconfluence in cell culture flasks, and subcultured twice a week. Caco-2 cells were used between passages 45 and 55. This study was conducted in accordance with the guidelines for the care and use of laboratory animals adopted by the U.S. National Institutes of Health. Morphine hydrochloride was purchased from Takeda Chemical Industries, Ltd. (Osaka, Japan). All other chemicals were purchased from commercial sources.
Antinociceptive Test The development of morphine tolerance was measured according to a method described previously 14) with a slight modification. Briefly, rats received morphine (100 mg/kg) orally once a day for 5 d, and the antinociceptive effects were determined in a tail-flick test with a thermal stimulus applied to the tail 15) once a day (120 min after morphine administration) to avoid tissue damage from repeated measurements. Before drug administration, baseline antinociceptive testing was performed. A maximum tail-flick latency of 10 s was used to minimize tissue damage to the tail. The tail-flick latency values were converted to a percent-age of the maximum possible effect (%MPE) as follows: %MPEϭ(postdrug latencyϪpredrug latency)/(maximum latencyϪpredrug latency)ϫ100.
Intestinal Absorption of Morphine Evaluated Using the in Situ Loop Method Rats received oral morphine (100 mg/kg) or saline once a day for 5 d. On the day (day 6) after the last administration, the intestinal absorption of morphine was determined using the in situ loop method. 16) Under sodium pentobarbital anesthesia, three loops (each 5 cm) were prepared in rats. The proximal ligature of the first loop (duodenal loop) was placed about 1 cm from the pylorus, that of the second loop (jejunal loop) was about 20 cm from the pylorus, and that of the third loop (ileal loop) was about 7 cm above the ileocecal junction. The bile duct was ligated in all experiments. After the contents of the loops were gently washed out with Tyrode's buffer (NaCl 137 mM, KCl 3 mM, CaCl 2 2 mM, MgCl 2 2 mM, NaH 2 PO 4 0.4 mM, and D-glucose 6 mM, pH 7.4), 0.5 ml of Tyrode's buffer containing morphine 10 mM was administered into each loop using a syringe. After 30 min, the solution in the loop was collected. Then, the mucosal side of the loop was rinsed with buffer to give a total volume of 2 ml. The fraction of absorbed morphine was estimated from the difference between the dose administered and the amount remaining in the loops. The absorption of phenol red, an unabsorbable marker, did not change after the repeated oral administration of morphine.
Transport Experiments Caco-2 cells were seeded at 1ϫ10 5 cells/cm 2 onto polycarbonate membrane Transwell inserts (Corning Co., Acton, MA, U.S.A.) in 12-well plates. The cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1% nonessential amino acids, penicillin 50 units/ml, and streptomycin 0.05 mg/ml. DMEM with or without morphine (10 mM) was changed every 2 d. After 21 d of culture, the cells were washed and incubated for 4 h with morphinefree DMEM for the washout of morphine before transport experiments. Hanks' balanced salt solution (HBSS) containing morphine 10 mM was added to the apical or basolateral chamber. The cells were incubated for 60, 120, and 180 min, and the morphine concentration in the other (receiver side) chamber that initially contained no morphine was determined as described below. Apparent permeability coefficients (P app ) were calculated according to the following equation:
where dQ/dt is the rate at which the morphine appears in the receiver chamber, C 0 is the initial concentration of morphine in the donor chamber, and A is the surface area of the cell monolayer. The transepithelial electrical resistance was measured routinely before and after experiments using the Millicell-ERS system (Millipore Co., Bedford, MA, U.S.A.) with readings from 200 to 400 W/cm 2 for all cells in this study.
Uptake and Efflux Experiments To evaluate P-glycoprotein-mediated efflux, the cellular accumulation of 3 H]vincristine or the fluorescence intensity of rhodamine123 was measured. The protein content was measured with a BCA protein assay kit (Pierce Chemical Co., Rockford, IL, U.S.A.). In the efflux experiments, Caco-2 cells were incubated with rhodamine123 3 mM for 90 min (loading time) at 37°C. After loading, the medium containing rhodamine123 was immediately removed, and the cells were incubated with HBSS for 90 min at 37°C. The cells were then washed with PBS, and after the cell solubilization, the fluorescence intensity of rhodamine123 was measured.
Determination of Morphine Concentrations of morphine were measured using high-performance liquid chromatography (HPLC) with fluorimetric detection. 18, 19) The samples were subjected to solid-phase extraction using an Oasis MCX cartridge (Waters, Milford, MA, U.S.A.), which was first prewet with methanol (1 ml) and then with water (1 ml). The sample was applied to the cartridge and washed with 1 ml of 0.1 N HCl and 1 ml of methanol; the morphine was then eluted with ethyl acetate with 5% NH 4 OH. The elution of morphine was dried under reduced pressure, and the residues were reconstituted in the HPLC mobile phase (6.4% acetonitrile containing 0.1% trifluoroacetic acid (TFA)). The HPLC system consisted of a pump (880-PU, JASCO, Tokyo, Japan), a fluorescence detector (RF-535, Shimadzu, Tokyo, Japan), and an integrator (C-R6A, Shimadzu). The analytical column comprised Nucleosil C 18 ODS (4.6 mmϫ250 mm, 5-mm particle size, GL Sciences, Tokyo, Japan). Gradient elution was carried out at room temperature at a constant flow rate of 1.0 ml/min. Solvent A was 0.1% TFA in water, and solvent B was 0.1% TFA in 40% acetonitrile. The initial condition was 6.4% acetonitrile. After the injection of a sample, the system was pumped isocratically for 2 min, then with a gradient of 6.4-20% acetonitrile over 10 min. This was followed by a gradient of 40% acetonitrile over 2 min to wash the column. The column elute was monitored fluorometrically at excitation and emission wavelengths of 280 and 335 nm, respectively.
Data Analysis Statistical analysis of the data was performed employing Student's t-test and one-way analysis of variance, followed by Dunnett's test for single and multiple comparisons. The differences were considered statistically significant at pϽ0.05.
RESULTS
Antinociceptive Effects after Repeated Oral Administration of Morphine in Rats
Rats were orally administered morphine (100 mg/kg) once a day for 5 d. The antinociceptive effects were measured using the tail-flick test 2 h after administration. The antinociceptive effects were 100% MPE on days 1 and 2, and 65%, 20%, and 5% MPE, respectively, on days 3, 4, and 5 ( Fig. 1) . Thus, pharmacologic tol-erance developed after the repeated oral administration of morphine in rats.
Rat Intestinal Absorption of Morphine The intestinal absorption of morphine in morphine-tolerant rats (100 mg/kg per os (p.o.), once a day for 5 d) was measured using the in situ loop method. Morphine absorption from the jejunum was significantly (53%) decreased in the morphine-treated rats (Fig. 2) . The absorption from the duodenum and ileum was decreased by 38% and 17%, respectively, but these changes were not significant.
Effects of Repeated Treatment with Morphine on the Transepithelial Transport of Morphine through Caco-2 Cell Monolayers
Morphine (10 mM) showed little differential transport between the apical to basolateral and the basolateral to apical direction through untreated Caco-2 cell monolayers (Fig. 3) . After repeated treatment with morphine (10 mM for 21 d), permeability to the drug (10 mM) was significantly (two-fold) greater in the basolateral to apical direction than in the apical to basolateral direction.
Effects of Repeated Treatment with Morphine on the Transport of [ 3 H]Vincristine and Rhodamine123 in Caco-2 Cells The accumulation of [
3 H]vincristine in Caco-2 cells increased with incubation time, and the cell-to-medium ratio reached a steady state at a value of 15 ml/mg protein after 60 min. The accumulation at 60 min increased significantly in the presence of verapamil (500 mM) and cyclosporin A (17 mM) by 18% and 64%, respectively (data not shown). The repeated addition of morphine (0.1-500 mM) to Caco-2 cells significantly reduced the amount of [ 3 H]vincristine accumulated by 12-20% in a concentration-dependent manner (Fig.  4A) . A significant decrease (approximately 10%) was seen after 12-h culture with morphine (10 mM), and a similar decrease (10-14%) was observed after culture for 1 to 14 d (Fig. 4B) . Moreover, cyclosporin A (17 mM) increased the accumulation. The decrease in the accumulation of [ 3 H]vincristine in Caco-2 cells after culture with morphine did not occur in the presence of cyclosporin A (Fig. 5) . The accumulation of rhodamine123 was also significantly inhibited in the presence of cyclosporin A, and was decreased by 10-15% after culture with morphine for 1-7 d (data not shown). The efflux of rhodamine123 from Caco-2 cells was significantly (1.4-fold and 2.5-fold, respectively) increased by preculture with morphine (10 mM) and digoxin (1 mM) (Fig. 6) . 
DISCUSSION
In the current study, we investigated the effects of repeated morphine administration on the antinociceptive effects, intestinal absorption, and transepithelial transport through Caco-2 cell monolayers. The oral administration of morphine significantly decreased its antinociceptive effects and intestinal absorption in rats. Further, in vitro experiments in Caco-2 cells suggested that repeated administration stimulated the P-glycoprotein-mediated efflux of morphine.
Patrick et al. reported that the chronic intraperitoneal infusion of morphine decreased the drug concentration in the brain with antinociceptive tolerance in rats. 20) However, there are few reports on the effects of chronic treatment on morphine pharmacokinetics including its oral bioavailability. Thus, the in vivo effects of repeated oral administration on the antinociceptive effects and absorption of this drug were investigated in rats. The oral administration of morphine for 4 or 5 d markedly decreased the antinociceptive effects, suggesting the development of tolerance. In the in situ loop absorption experiment with morphine-tolerant rats, there was a significant decrease in the absorption of morphine from the jejunum. Morphine is absorbed better from jejunal sites than from duodenal and ileal sites. 21) The decreased absorption from the jejunum may cause a decrease in the oral bioavailability of the drug. Therefore the reduction in intestinal absorption might contribute significantly to the development of morphine tolerance. Further studies are required to clarify the effects of repeated oral administration on the in vivo intestinal absorption of morphine.
We also investigated the effects of morphine on transepithelial transport in Caco-2 cells. The Caco-2 line is frequently used as an intestinal model for the prediction of drug absorption. 22) Repeated morphine administration caused an increase in the permeability of Caco-2 monolayers in the basolateral to apical direction and a decrease in the apical to basolateral direction. Thus the basolateral to apical transport was 2-fold greater than the apical to basolateral transport after repeated administration of morphine, suggesting an increase in the efflux of morphine after repeated administration. To our knowledge, this is the first report to demonstrate significant effects of repeated morphine administration on transepithelial permeability. P-glycoprotein mediates the efflux of morphine and affects the intestinal absorption of morphine in humans. 4) Thus the effects of morphine administration on P-glycoproteinmediated transport was characterized in Caco-2 cells using Since the accumulation was restored to the control level by the addition of cyclosporin A, it is suggested that the decrease in [ 3 H]vincristine accumulation is due to the stimulatory effects on P-glycoprotein-mediated efflux. The accumulation of rhodamine123 was also decreased after culture with morphine, and the efflux of rhodamine123 from Caco-2 cells was significantly increased after culture with morphine. These results suggest that the repeated culture with morphine enhances P-glycoprotein-mediated efflux in Caco-2 cells. It was reported that the addition of digoxin increases the efflux of rhodamine123 and reduces the cytotoxicity of paclitaxel, a P-glycoprotein substrate, in Caco-2 cells. 17) Although the increase (1.4-fold) in the efflux of rhodamine123 with the addition of morphine was less than that (2.5-fold) with the addition of digoxin, the enhancement of P-glycoprotein-mediated efflux is considered to affect significantly the transepithelial transport of morphine through Caco-2 cell monolayers after repeated culture with morphine.
In relation to the mechanism underlying the stimulation of P-glycoprotein-mediated efflux, we measured MDR1 mRNA in Caco-2 cells after culture with morphine (10 mM for 1-3 d) or digoxin (1 mM for 24 h) (our unpublished data). MDR1 mRNA expression in Caco-2 cells was increased after the addition of digoxin but not after that of morphine, suggesting that digoxin upregulates MDR1 mRNA while morphine does not regulate transcriptional expression of P-glycoprotein in Caco-2 cells.
The morphine concentration (10 mM) used in the current transport experiment was about 50-fold greater than the mean plasma concentration (223 nM) in patients with chronic cancer pain receiving oral morphine. 24) However, the concentration in the intestinal lumen after oral administration was The cells were cultured with morphine (10 mM) or digoxin (1 mM) for 24 h and then incubated with rhodamine123 3 mM at 37°C for 90 min. Next, the cells were incubated with rhodamine123-free HBSS at 37°C for 90 min. Each column represents the meanϮS.E. of three experiments. * pϽ0.05, * * pϽ0.01 vs. control. much higher than the plasma concentration. Repeated administration caused significant decreases in the antinociceptive effects and intestinal absorption of morphine in rats, suggesting that a reduction in the absorption of morphine occurred at pharmacologically relevant doses. Therefore repeated oral administration may stimulate the intestinal efflux of morphine, leading to a decrease in the oral bioavailability and antinociceptive effects of the drug.
In conclusion, the results of the current study suggest that repeated morphine administration in rats reduces the intestinal absorption of this drug, subsequently decreasing its antinociceptive effects. The decrease in absorption may be related, at least in part, to the stimulation of P-glycoproteinmediated efflux. These findings may be relevant to the development of morphine tolerance after oral administration. Further study will be required to clarify the mechanisms underlying morphine tolerance in relation to intestinal absorption.
